Key Insights
The global intragastric balloon market is projected to experience significant expansion, reaching an estimated market size of 53.69 million by 2025, with a compelling Compound Annual Growth Rate (CAGR) of 9.15% from the base year 2025. This growth is propelled by the increasing global prevalence of obesity and associated comorbidities, alongside a rising preference for minimally invasive bariatric interventions among both patients and physicians. Ongoing innovation in balloon technology, including dual and triple balloon systems for enhanced satiety and weight loss, and the integration of smart monitoring features, are key drivers. Advancements in filling materials, such as gas-filled and saline-filled balloons, cater to diverse patient needs regarding safety, efficacy, and comfort.

Intragastric Balloon Industry Market Size (In Million)

Market dynamics are further influenced by the growing adoption of intragastric balloons in ambulatory surgical centers, indicating a trend towards cost-effective and convenient outpatient bariatric procedures. Emerging economies, particularly in the Asia Pacific region, present a substantial growth opportunity due to increasing healthcare expenditure and heightened awareness of weight management solutions. Leading companies such as Allurion Technologies Inc., Apollo Endosurgery Inc., and Obalon Therapeutics are actively investing in R&D for next-generation devices and global market expansion. While procedural costs, reimbursement complexities, and the necessity for sustained lifestyle modifications remain potential challenges, the inherent advantages of intragastric balloons over traditional surgical approaches continue to drive their adoption across key end-user segments.

Intragastric Balloon Industry Company Market Share

Intragastric Balloon Industry Market Analysis: Comprehensive Report 2019-2033
Unlock the future of non-surgical weight loss with this definitive Intragastric Balloon Industry report. Covering a study period of 2019–2033, with a base and estimated year of 2025, this in-depth analysis delves into market dynamics, key players, technological advancements, and future opportunities within the burgeoning global intragastric balloon market. This report is an essential resource for medical device manufacturers, healthcare providers, investors, and regulatory bodies seeking to capitalize on the rapidly expanding bariatric surgery alternatives and medical device innovation landscape.
Intragastric Balloon Industry Market Concentration & Dynamics
The intragastric balloon market is characterized by a dynamic interplay of established players and emerging innovators, reflecting significant market concentration with a few key companies holding substantial market share. Innovation ecosystems are rapidly developing, driven by advancements in swallowable gastric balloon technology and minimally invasive procedures. Regulatory frameworks are evolving to accommodate these novel solutions, with a keen eye on patient safety and efficacy. Substitute products, primarily traditional bariatric surgeries and other obesity management devices, continue to pose a competitive challenge, though intragastric balloons offer distinct advantages in terms of reduced invasiveness and shorter recovery times. End-user trends are shifting towards less intrusive weight loss solutions, fueling demand in ambulatory surgical centers and specialized clinics. Merger and acquisition (M&A) activities, though currently limited, are anticipated to increase as the market matures and consolidation opportunities arise. The market is projected to see a rise in M&A deal counts as companies seek to expand their product portfolios and geographical reach.
- Market Concentration: Moderate to High, with key players dominating specific segments.
- Innovation Ecosystem: Robust, with strong emphasis on swallowable gastric balloons and AI-powered patient monitoring.
- Regulatory Frameworks: Evolving, with increasing focus on non-surgical weight loss treatments.
- Substitute Products: Traditional bariatric surgery, diet programs, and exercise regimens.
- End-User Trends: Growing preference for minimally invasive obesity solutions.
- M&A Activities: Currently limited, with potential for future consolidation.
Intragastric Balloon Industry Industry Insights & Trends
The intragastric balloon industry is poised for substantial growth, driven by the escalating global obesity epidemic and a growing consumer demand for effective, non-surgical weight management solutions. The market size, estimated to be in the range of $500 Million in 2025, is projected to witness a significant Compound Annual Growth Rate (CAGR) of approximately 8-10% during the forecast period of 2025–2033. Technological disruptions are at the forefront, with the advent of allurion elipse balloon and other swallowable intragastric balloons revolutionizing patient experience by eliminating the need for endoscopic procedures or anesthesia. This innovation directly addresses a major barrier to traditional bariatric interventions – patient apprehension regarding surgery. Evolving consumer behaviors, influenced by increased awareness of health risks associated with obesity and a desire for quicker, less invasive recovery, are further accelerating market adoption. The integration of digital health technologies, such as remote patient monitoring via mobile apps and AI-powered insights, is enhancing treatment efficacy and patient engagement, creating a holistic approach to weight loss. The market is benefiting from increasing healthcare infrastructure development in emerging economies, making these advanced medical devices more accessible to a wider population. The demand for saline filled and gas filled balloons continues to be robust, catering to different clinical needs and patient preferences. The shift towards personalized bariatric device solutions will also play a crucial role in shaping future market trends.
Key Markets & Segments Leading Intragastric Balloon Industry
North America currently leads the intragastric balloon industry, driven by a high prevalence of obesity, advanced healthcare infrastructure, and strong patient adoption of innovative weight loss procedures. Within North America, the United States represents the largest market due to high disposable incomes and a proactive approach to health and wellness. The Type segment is witnessing a significant shift towards Single balloons, particularly the newer swallowable versions, although Dual and Triple balloon systems are also gaining traction for more complex cases. The Filling Material segment sees continued demand for both Saline Filled and Gas Filled balloons, with advancements in gas-filled technology offering potential advantages in patient comfort and efficacy. The End User segment is dominated by Hospitals and Ambulatory Surgical Centers, which are increasingly equipped to offer these minimally invasive obesity treatment devices. However, there is a growing trend of specialized bariatric clinics and even direct-to-consumer models for swallowable balloons, expanding accessibility.
Dominant Region: North America, particularly the United States.
Key Market Drivers:
- High prevalence of obesity and related comorbidities.
- Advanced healthcare infrastructure and reimbursement policies.
- Strong patient acceptance of minimally invasive weight loss solutions.
- Increased R&D investments by key players.
- Growing awareness and demand for non-surgical bariatric interventions.
Dominant Segments:
- Type: Single balloons (increasingly swallowable), followed by Dual and Triple balloon systems for more extensive weight loss.
- Filling Material: Both Saline Filled and Gas Filled balloons are significant, with advancements in both categories.
- End User: Hospitals and Ambulatory Surgical Centers remain primary channels, with a rising presence of specialized weight loss clinics.
Intragastric Balloon Industry Product Developments
Product innovation is a cornerstone of the intragastric balloon industry. The development of swallowable intragastric balloons, exemplified by the Allurion Balloon, represents a significant leap, offering a non-surgical, non-endoscopic placement and removal. These advancements are crucial for enhancing patient compliance and reducing the perceived burden of treatment. The integration of remote patient monitoring systems, such as the Allurion Virtual Care Suite, which includes AI-powered platforms, mobile apps, connected scales, and health trackers, is transforming post-procedure care and improving long-term outcomes. These integrated solutions provide personalized coaching and real-time data, offering a competitive edge to manufacturers and significant value to patients seeking sustained weight loss.
Challenges in the Intragastric Balloon Industry Market
Despite its promising growth, the intragastric balloon market faces several challenges. Stringent regulatory approvals for novel medical devices can lead to extended market entry timelines. High initial costs associated with some obesity management technologies can be a barrier for certain patient populations and healthcare systems. Intense competition from established bariatric surgical procedures and an increasing array of non-invasive weight loss therapies requires continuous innovation and value demonstration. Furthermore, ensuring consistent product quality and addressing potential adverse events through robust post-market surveillance are critical for maintaining patient and physician confidence. The limited availability of trained healthcare professionals in some regions can also hinder widespread adoption of these bariatric balloons.
Forces Driving Intragastric Balloon Industry Growth
Several potent forces are propelling the growth of the intragastric balloon industry. The global surge in obesity rates and associated health complications, such as diabetes and cardiovascular diseases, is a primary driver, increasing the demand for effective weight loss treatments. Technological advancements, particularly the development of swallowable gastric balloons, are making these interventions more accessible and appealing to a broader patient base. Favorable reimbursement policies in key markets and increasing healthcare expenditure are also contributing to market expansion. Growing patient awareness and a preference for minimally invasive procedures over traditional surgery further bolster demand for intragastric balloons.
Challenges in the Intragastric Balloon Industry Market
Long-term growth catalysts for the intragastric balloon market lie in continued technological innovation and strategic market expansion. The development of next-generation bariatric devices with enhanced efficacy and patient comfort will be crucial. Strategic partnerships between medical device companies, healthcare providers, and insurance payers can facilitate wider access and adoption. Penetrating emerging markets with a growing burden of obesity and a developing healthcare infrastructure presents significant growth opportunities. Furthermore, the increasing focus on integrated weight management programs, combining devices with lifestyle coaching and digital health solutions, will foster patient engagement and long-term success, solidifying the position of intragastric balloons in the obesity treatment landscape.
Emerging Opportunities in Intragastric Balloon Industry
Emerging opportunities in the intragastric balloon industry are multifaceted. The expansion into emerging economies, where the obesity epidemic is rapidly growing, presents a vast untapped market. Advancements in AI-powered weight loss solutions and personalized treatment plans will create differentiated offerings. The development of balloons designed for specific patient profiles or longer-term efficacy is also an area of significant potential. Furthermore, the increasing integration of intragastric balloons into comprehensive metabolic health programs and their potential use in managing other comorbidities beyond obesity are exciting avenues for future growth.
Leading Players in the Intragastric Balloon Industry Sector
- Allurion Technologies Inc
- Hélioscopie
- MEDSIL
- Spatz
- Endalis
- Lexel Medical
- Obalon Therapeutics
- Silimed
- Apollo Endosurgery Inc
- ReShape Lifesciences
Key Milestones in Intragastric Balloon Industry Industry
- October 2022: Allurion received approval to launch its revolutionary gastric balloon technology in Brazil. The Allurion Balloon, known in Brazil as the Elipse Balloon, is the first and only intragastric weight-loss balloon that is routinely placed and removed without surgery, endoscopy, or anesthesia, significantly impacting non-surgical weight loss market accessibility.
- September 2022: Allurion launched its swallowable gastric balloon capsule for weight loss in India. Allurion launched a complete weight loss program in India that includes the Allurion Swallowable Capsule, the Allurion Virtual Care Suite, a remote patient monitoring solution powered by the Allurion Iris AI platform that includes the Allurion Mobile App, Connected Scale, and Health Tracker, setting a new standard for integrated medical device and digital health solutions in the bariatric sector.
Strategic Outlook for Intragastric Balloon Industry Market
The strategic outlook for the intragastric balloon industry market remains exceptionally positive, driven by a convergence of escalating global health challenges and continuous technological innovation. Future growth accelerators will center on the further refinement of swallowable balloon technology, enhancing patient convenience and expanding its applicability across diverse demographics. Strategic investments in research and development for next-generation obesity treatment devices, focusing on improved satiety mechanisms and personalized weight loss trajectories, will be paramount. Furthermore, forging robust partnerships with healthcare systems and payers to improve reimbursement and access will unlock significant market potential. The integration of advanced digital health platforms and AI will be crucial for providing comprehensive, data-driven weight management solutions, solidifying the intragastric balloon's position as a vital tool in the fight against obesity.
Intragastric Balloon Industry Segmentation
-
1. Type
- 1.1. Single
- 1.2. Dual
- 1.3. Triple
-
2. Filling Material
- 2.1. Gas Filled
- 2.2. Saline Filled
-
3. End User
- 3.1. Hospitals
- 3.2. Ambulatory Surgical Centers
- 3.3. Others
Intragastric Balloon Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
- 4. Rest of the World

Intragastric Balloon Industry Regional Market Share

Geographic Coverage of Intragastric Balloon Industry
Intragastric Balloon Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 9.15% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Adoption of Minimally Invasive Treatment; Increasing Prevalence of Obesity
- 3.3. Market Restrains
- 3.3.1. Side Effects or Complications Associated with Intragastric Balloons
- 3.4. Market Trends
- 3.4.1. Single Intragastric Balloon Segment is Expected to Witness Significant Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Intragastric Balloon Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Single
- 5.1.2. Dual
- 5.1.3. Triple
- 5.2. Market Analysis, Insights and Forecast - by Filling Material
- 5.2.1. Gas Filled
- 5.2.2. Saline Filled
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospitals
- 5.3.2. Ambulatory Surgical Centers
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Rest of the World
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America Intragastric Balloon Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Single
- 6.1.2. Dual
- 6.1.3. Triple
- 6.2. Market Analysis, Insights and Forecast - by Filling Material
- 6.2.1. Gas Filled
- 6.2.2. Saline Filled
- 6.3. Market Analysis, Insights and Forecast - by End User
- 6.3.1. Hospitals
- 6.3.2. Ambulatory Surgical Centers
- 6.3.3. Others
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. Europe Intragastric Balloon Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Single
- 7.1.2. Dual
- 7.1.3. Triple
- 7.2. Market Analysis, Insights and Forecast - by Filling Material
- 7.2.1. Gas Filled
- 7.2.2. Saline Filled
- 7.3. Market Analysis, Insights and Forecast - by End User
- 7.3.1. Hospitals
- 7.3.2. Ambulatory Surgical Centers
- 7.3.3. Others
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Asia Pacific Intragastric Balloon Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Single
- 8.1.2. Dual
- 8.1.3. Triple
- 8.2. Market Analysis, Insights and Forecast - by Filling Material
- 8.2.1. Gas Filled
- 8.2.2. Saline Filled
- 8.3. Market Analysis, Insights and Forecast - by End User
- 8.3.1. Hospitals
- 8.3.2. Ambulatory Surgical Centers
- 8.3.3. Others
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Rest of the World Intragastric Balloon Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Single
- 9.1.2. Dual
- 9.1.3. Triple
- 9.2. Market Analysis, Insights and Forecast - by Filling Material
- 9.2.1. Gas Filled
- 9.2.2. Saline Filled
- 9.3. Market Analysis, Insights and Forecast - by End User
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Others
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis 2025
- 10.2. Company Profiles
- 10.2.1 Allurion Technologies Inc
- 10.2.1.1. Overview
- 10.2.1.2. Products
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Financials (Based on Availability)
- 10.2.2 Hélioscopie
- 10.2.2.1. Overview
- 10.2.2.2. Products
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Financials (Based on Availability)
- 10.2.3 MEDSIL
- 10.2.3.1. Overview
- 10.2.3.2. Products
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Financials (Based on Availability)
- 10.2.4 Spatz
- 10.2.4.1. Overview
- 10.2.4.2. Products
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Financials (Based on Availability)
- 10.2.5 Endalis
- 10.2.5.1. Overview
- 10.2.5.2. Products
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Financials (Based on Availability)
- 10.2.6 Lexel Medical
- 10.2.6.1. Overview
- 10.2.6.2. Products
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Financials (Based on Availability)
- 10.2.7 Obalon Therapeutics
- 10.2.7.1. Overview
- 10.2.7.2. Products
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Financials (Based on Availability)
- 10.2.8 Silimed
- 10.2.8.1. Overview
- 10.2.8.2. Products
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Financials (Based on Availability)
- 10.2.9 Apollo Endosurgery Inc
- 10.2.9.1. Overview
- 10.2.9.2. Products
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Financials (Based on Availability)
- 10.2.10 ReShape Lifesciences
- 10.2.10.1. Overview
- 10.2.10.2. Products
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Financials (Based on Availability)
- 10.2.1 Allurion Technologies Inc
List of Figures
- Figure 1: Global Intragastric Balloon Industry Revenue Breakdown (million, %) by Region 2025 & 2033
- Figure 2: Global Intragastric Balloon Industry Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America Intragastric Balloon Industry Revenue (million), by Type 2025 & 2033
- Figure 4: North America Intragastric Balloon Industry Volume (K Unit), by Type 2025 & 2033
- Figure 5: North America Intragastric Balloon Industry Revenue Share (%), by Type 2025 & 2033
- Figure 6: North America Intragastric Balloon Industry Volume Share (%), by Type 2025 & 2033
- Figure 7: North America Intragastric Balloon Industry Revenue (million), by Filling Material 2025 & 2033
- Figure 8: North America Intragastric Balloon Industry Volume (K Unit), by Filling Material 2025 & 2033
- Figure 9: North America Intragastric Balloon Industry Revenue Share (%), by Filling Material 2025 & 2033
- Figure 10: North America Intragastric Balloon Industry Volume Share (%), by Filling Material 2025 & 2033
- Figure 11: North America Intragastric Balloon Industry Revenue (million), by End User 2025 & 2033
- Figure 12: North America Intragastric Balloon Industry Volume (K Unit), by End User 2025 & 2033
- Figure 13: North America Intragastric Balloon Industry Revenue Share (%), by End User 2025 & 2033
- Figure 14: North America Intragastric Balloon Industry Volume Share (%), by End User 2025 & 2033
- Figure 15: North America Intragastric Balloon Industry Revenue (million), by Country 2025 & 2033
- Figure 16: North America Intragastric Balloon Industry Volume (K Unit), by Country 2025 & 2033
- Figure 17: North America Intragastric Balloon Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: North America Intragastric Balloon Industry Volume Share (%), by Country 2025 & 2033
- Figure 19: Europe Intragastric Balloon Industry Revenue (million), by Type 2025 & 2033
- Figure 20: Europe Intragastric Balloon Industry Volume (K Unit), by Type 2025 & 2033
- Figure 21: Europe Intragastric Balloon Industry Revenue Share (%), by Type 2025 & 2033
- Figure 22: Europe Intragastric Balloon Industry Volume Share (%), by Type 2025 & 2033
- Figure 23: Europe Intragastric Balloon Industry Revenue (million), by Filling Material 2025 & 2033
- Figure 24: Europe Intragastric Balloon Industry Volume (K Unit), by Filling Material 2025 & 2033
- Figure 25: Europe Intragastric Balloon Industry Revenue Share (%), by Filling Material 2025 & 2033
- Figure 26: Europe Intragastric Balloon Industry Volume Share (%), by Filling Material 2025 & 2033
- Figure 27: Europe Intragastric Balloon Industry Revenue (million), by End User 2025 & 2033
- Figure 28: Europe Intragastric Balloon Industry Volume (K Unit), by End User 2025 & 2033
- Figure 29: Europe Intragastric Balloon Industry Revenue Share (%), by End User 2025 & 2033
- Figure 30: Europe Intragastric Balloon Industry Volume Share (%), by End User 2025 & 2033
- Figure 31: Europe Intragastric Balloon Industry Revenue (million), by Country 2025 & 2033
- Figure 32: Europe Intragastric Balloon Industry Volume (K Unit), by Country 2025 & 2033
- Figure 33: Europe Intragastric Balloon Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: Europe Intragastric Balloon Industry Volume Share (%), by Country 2025 & 2033
- Figure 35: Asia Pacific Intragastric Balloon Industry Revenue (million), by Type 2025 & 2033
- Figure 36: Asia Pacific Intragastric Balloon Industry Volume (K Unit), by Type 2025 & 2033
- Figure 37: Asia Pacific Intragastric Balloon Industry Revenue Share (%), by Type 2025 & 2033
- Figure 38: Asia Pacific Intragastric Balloon Industry Volume Share (%), by Type 2025 & 2033
- Figure 39: Asia Pacific Intragastric Balloon Industry Revenue (million), by Filling Material 2025 & 2033
- Figure 40: Asia Pacific Intragastric Balloon Industry Volume (K Unit), by Filling Material 2025 & 2033
- Figure 41: Asia Pacific Intragastric Balloon Industry Revenue Share (%), by Filling Material 2025 & 2033
- Figure 42: Asia Pacific Intragastric Balloon Industry Volume Share (%), by Filling Material 2025 & 2033
- Figure 43: Asia Pacific Intragastric Balloon Industry Revenue (million), by End User 2025 & 2033
- Figure 44: Asia Pacific Intragastric Balloon Industry Volume (K Unit), by End User 2025 & 2033
- Figure 45: Asia Pacific Intragastric Balloon Industry Revenue Share (%), by End User 2025 & 2033
- Figure 46: Asia Pacific Intragastric Balloon Industry Volume Share (%), by End User 2025 & 2033
- Figure 47: Asia Pacific Intragastric Balloon Industry Revenue (million), by Country 2025 & 2033
- Figure 48: Asia Pacific Intragastric Balloon Industry Volume (K Unit), by Country 2025 & 2033
- Figure 49: Asia Pacific Intragastric Balloon Industry Revenue Share (%), by Country 2025 & 2033
- Figure 50: Asia Pacific Intragastric Balloon Industry Volume Share (%), by Country 2025 & 2033
- Figure 51: Rest of the World Intragastric Balloon Industry Revenue (million), by Type 2025 & 2033
- Figure 52: Rest of the World Intragastric Balloon Industry Volume (K Unit), by Type 2025 & 2033
- Figure 53: Rest of the World Intragastric Balloon Industry Revenue Share (%), by Type 2025 & 2033
- Figure 54: Rest of the World Intragastric Balloon Industry Volume Share (%), by Type 2025 & 2033
- Figure 55: Rest of the World Intragastric Balloon Industry Revenue (million), by Filling Material 2025 & 2033
- Figure 56: Rest of the World Intragastric Balloon Industry Volume (K Unit), by Filling Material 2025 & 2033
- Figure 57: Rest of the World Intragastric Balloon Industry Revenue Share (%), by Filling Material 2025 & 2033
- Figure 58: Rest of the World Intragastric Balloon Industry Volume Share (%), by Filling Material 2025 & 2033
- Figure 59: Rest of the World Intragastric Balloon Industry Revenue (million), by End User 2025 & 2033
- Figure 60: Rest of the World Intragastric Balloon Industry Volume (K Unit), by End User 2025 & 2033
- Figure 61: Rest of the World Intragastric Balloon Industry Revenue Share (%), by End User 2025 & 2033
- Figure 62: Rest of the World Intragastric Balloon Industry Volume Share (%), by End User 2025 & 2033
- Figure 63: Rest of the World Intragastric Balloon Industry Revenue (million), by Country 2025 & 2033
- Figure 64: Rest of the World Intragastric Balloon Industry Volume (K Unit), by Country 2025 & 2033
- Figure 65: Rest of the World Intragastric Balloon Industry Revenue Share (%), by Country 2025 & 2033
- Figure 66: Rest of the World Intragastric Balloon Industry Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Intragastric Balloon Industry Revenue million Forecast, by Type 2020 & 2033
- Table 2: Global Intragastric Balloon Industry Volume K Unit Forecast, by Type 2020 & 2033
- Table 3: Global Intragastric Balloon Industry Revenue million Forecast, by Filling Material 2020 & 2033
- Table 4: Global Intragastric Balloon Industry Volume K Unit Forecast, by Filling Material 2020 & 2033
- Table 5: Global Intragastric Balloon Industry Revenue million Forecast, by End User 2020 & 2033
- Table 6: Global Intragastric Balloon Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 7: Global Intragastric Balloon Industry Revenue million Forecast, by Region 2020 & 2033
- Table 8: Global Intragastric Balloon Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: Global Intragastric Balloon Industry Revenue million Forecast, by Type 2020 & 2033
- Table 10: Global Intragastric Balloon Industry Volume K Unit Forecast, by Type 2020 & 2033
- Table 11: Global Intragastric Balloon Industry Revenue million Forecast, by Filling Material 2020 & 2033
- Table 12: Global Intragastric Balloon Industry Volume K Unit Forecast, by Filling Material 2020 & 2033
- Table 13: Global Intragastric Balloon Industry Revenue million Forecast, by End User 2020 & 2033
- Table 14: Global Intragastric Balloon Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 15: Global Intragastric Balloon Industry Revenue million Forecast, by Country 2020 & 2033
- Table 16: Global Intragastric Balloon Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 17: United States Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 18: United States Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 19: Canada Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 20: Canada Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 21: Mexico Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 22: Mexico Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 23: Global Intragastric Balloon Industry Revenue million Forecast, by Type 2020 & 2033
- Table 24: Global Intragastric Balloon Industry Volume K Unit Forecast, by Type 2020 & 2033
- Table 25: Global Intragastric Balloon Industry Revenue million Forecast, by Filling Material 2020 & 2033
- Table 26: Global Intragastric Balloon Industry Volume K Unit Forecast, by Filling Material 2020 & 2033
- Table 27: Global Intragastric Balloon Industry Revenue million Forecast, by End User 2020 & 2033
- Table 28: Global Intragastric Balloon Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 29: Global Intragastric Balloon Industry Revenue million Forecast, by Country 2020 & 2033
- Table 30: Global Intragastric Balloon Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 31: Germany Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 32: Germany Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: United Kingdom Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 34: United Kingdom Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: France Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 36: France Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Italy Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 38: Italy Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 39: Spain Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 40: Spain Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 41: Rest of Europe Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 42: Rest of Europe Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 43: Global Intragastric Balloon Industry Revenue million Forecast, by Type 2020 & 2033
- Table 44: Global Intragastric Balloon Industry Volume K Unit Forecast, by Type 2020 & 2033
- Table 45: Global Intragastric Balloon Industry Revenue million Forecast, by Filling Material 2020 & 2033
- Table 46: Global Intragastric Balloon Industry Volume K Unit Forecast, by Filling Material 2020 & 2033
- Table 47: Global Intragastric Balloon Industry Revenue million Forecast, by End User 2020 & 2033
- Table 48: Global Intragastric Balloon Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 49: Global Intragastric Balloon Industry Revenue million Forecast, by Country 2020 & 2033
- Table 50: Global Intragastric Balloon Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 51: China Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 52: China Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Japan Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 54: Japan Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: India Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 56: India Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 57: Australia Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 58: Australia Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 59: South Korea Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 60: South Korea Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 61: Rest of Asia Pacific Intragastric Balloon Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 62: Rest of Asia Pacific Intragastric Balloon Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: Global Intragastric Balloon Industry Revenue million Forecast, by Type 2020 & 2033
- Table 64: Global Intragastric Balloon Industry Volume K Unit Forecast, by Type 2020 & 2033
- Table 65: Global Intragastric Balloon Industry Revenue million Forecast, by Filling Material 2020 & 2033
- Table 66: Global Intragastric Balloon Industry Volume K Unit Forecast, by Filling Material 2020 & 2033
- Table 67: Global Intragastric Balloon Industry Revenue million Forecast, by End User 2020 & 2033
- Table 68: Global Intragastric Balloon Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 69: Global Intragastric Balloon Industry Revenue million Forecast, by Country 2020 & 2033
- Table 70: Global Intragastric Balloon Industry Volume K Unit Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Intragastric Balloon Industry?
The projected CAGR is approximately 9.15%.
2. Which companies are prominent players in the Intragastric Balloon Industry?
Key companies in the market include Allurion Technologies Inc, Hélioscopie, MEDSIL, Spatz, Endalis, Lexel Medical, Obalon Therapeutics, Silimed, Apollo Endosurgery Inc, ReShape Lifesciences.
3. What are the main segments of the Intragastric Balloon Industry?
The market segments include Type, Filling Material, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 53.69 million as of 2022.
5. What are some drivers contributing to market growth?
Rising Adoption of Minimally Invasive Treatment; Increasing Prevalence of Obesity.
6. What are the notable trends driving market growth?
Single Intragastric Balloon Segment is Expected to Witness Significant Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Side Effects or Complications Associated with Intragastric Balloons.
8. Can you provide examples of recent developments in the market?
October 2022: Allurion received approval to launch its revolutionary gastric balloon technology in Brazil. The Allurion Balloon, known in Brazil as the Elipse Balloon, is the first and only intragastric weight-loss balloon that is routinely placed and removed without surgery, endoscopy, or anesthesia.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Intragastric Balloon Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Intragastric Balloon Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Intragastric Balloon Industry?
To stay informed about further developments, trends, and reports in the Intragastric Balloon Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

